Fact CheckerSign in

NCT07004790Not yet recruiting

Prognostic Value of Transcranial Doppler Ultrasound in the Clinical Evolution of Patients With Acute Ischemic Stroke. The TRADE-AIS Study

Prognostic Value of Transcranial Doppler Ultrasound in the Clinical Evolution of Patients With Acute Ischemic Stroke: A Prospective Observational Study

Source: ClinicalTrials.gov · Last updated 16 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This prospective observational study aims to determine whether specific parameters measured by transcranial Doppler ultrasound (TCD) can predict clinical outcomes in patients with acute ischemic stroke (AIS). The primary objective is to evaluate the association between middle cerebral artery (MCA) flow velocities and short-term neurological improvement. Secondary outcomes include the presence of collateral flow and flow patterns in relation to functional recovery measured by NIHSS and modified Rankin Scale (mRS) scores.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
27 May 2025
Start date
1 Aug 2026
Primary completion date
31 Jul 2027
Lead sponsor
Jose Ivan Rodriguez de Molina Serrano
Diseases
Stroke
NCT number
NCT07004790

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 1 Aug 2026 to the primary completion date, 31 Jul 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Intubated or hemodynamically unstable prior to Doppler evaluation

Other illness

  • Evidence of intracerebral hemorrhage on imaging
  • Known diagnosis of neurodegenerative disease significantly affecting baseline neurological function (e.g., advanced dementia, Parkinson's disease)

Other

  • Inadequate temporal acoustic window for transcranial Doppler
  • Refusal to participate or withdrawal of consent

Who the study is looking for

  • Age ≥ 18 years
  • Clinical diagnosis of acute ischemic stroke
  • Onset of symptoms ≤ 24 hours before admission
  • Underwent or will undergo transcranial Doppler ultrasound within 24 hours of symptom onset
  • Able to provide informed consent or consent obtained from a legal representative

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.